APA (7th ed.) Citation

Wick, A., Sander, A., Koch, M., Bendszus, M., Combs, S., Haut, T., . . . Keßler, T. (2022). Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: The NOA-18 trial. BMC cancer, 22, . https://doi.org/10.1186/s12885-022-09720-z

Chicago Style (17th ed.) Citation

Wick, Antje, et al. "Improvement of Functional Outcome for Patients with Newly Diagnosed Grade 2 or 3 Gliomas with Co-deletion of 1p/19q - IMPROVE CODEL: The NOA-18 Trial." BMC Cancer 22 (2022). https://doi.org/10.1186/s12885-022-09720-z.

MLA (9th ed.) Citation

Wick, Antje, et al. "Improvement of Functional Outcome for Patients with Newly Diagnosed Grade 2 or 3 Gliomas with Co-deletion of 1p/19q - IMPROVE CODEL: The NOA-18 Trial." BMC Cancer, vol. 22, 2022, https://doi.org/10.1186/s12885-022-09720-z.